|Aegis Capital Corp.||Robert LeBoyer||(646) 502-2494 | email@example.com|
|BTIG LLC||Robert C. Hazlett||(212) 738-6145 | firstname.lastname@example.org|
|H.C. Wainwright & Co.||Andrew S. Fein||212-356-0546 | email@example.com|
|Maxim Group||Jason McCarthy, Ph.D.||(212) 895-3556 | firstname.lastname@example.org|
|ROTH Capital Partners, LLC||Jerry Isaacson, Ph.D.||(406) 425-0563 | email@example.com|
Matinas BioPharma Holdings, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Matinas BioPharma Holdings, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Matinas BioPharma Holdings, Inc. or its management. Matinas BioPharma Holdings, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.